Erlotinib-13C6 is a 13C-labeled form of Erlotinib, which is a direct EGFR tyrosine kinase inhibitor with an IC50 of 2 nM against human EGFR; used as an internal standard in mass spectrometry-based quantitative analysis and in pharmacokinetic studies.